Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms- |
Target |
Action antagonists, inhibitors |
Mechanism IGF-1R antagonists(Insulin-like growth factor I receptor antagonists), SRC inhibitors(Tyrosine-protein kinase SRC inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC36H32N8O6 |
InChIKeyBLGABOHGKRXYSB-UHFFFAOYSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | South Korea | 23 Apr 2020 |